List of Excipients in API hydroxychloroquine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing hydroxychloroquine
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Aphena Pharma Solutions - Tennessee LLC | HYDROXYCHLOROQUINE SULFATE | hydroxychloroquine sulfate | 43353-051 | CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | |
| Aphena Pharma Solutions - Tennessee LLC | HYDROXYCHLOROQUINE SULFATE | hydroxychloroquine sulfate | 43353-051 | CARNAUBA WAX | |
| Aphena Pharma Solutions - Tennessee LLC | HYDROXYCHLOROQUINE SULFATE | hydroxychloroquine sulfate | 43353-051 | FERROSOFERRIC OXIDE | |
| Aphena Pharma Solutions - Tennessee LLC | HYDROXYCHLOROQUINE SULFATE | hydroxychloroquine sulfate | 43353-051 | HYPROMELLOSE 2910 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing hydroxychloroquine
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 | CROSPOVIDONE |
| Chartwell RX LLC | hydroxychloroquine | 62135-752 | HYPROMELLOSE |
| Chartwell RX LLC | hydroxychloroquine | 62135-752 | LACTOSE MONOHYDRATE |
| Chartwell RX LLC | hydroxychloroquine | 62135-752 | MAGNESIUM STEARATE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for hydroxychloroquine
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
hydroxychloroquine drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | hydroxychloroquine sulfate | 0781-1407 |
| Sandoz Inc | hydroxychloroquine sulfate | 0781-5994 |
| Major Pharmaceuticals | hydroxychloroquine sulfate | 0904-6884 |
| Northstar RxLLC | hydroxychloroquine sulfate | 16714-753 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS LACTOSE
hydroxychloroquine drug variants containing ANHYDROUS LACTOSE
hydroxychloroquine drug variants not containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| NCS HealthCare of KY Inc dba Vangard Labs | hydroxychloroquine sulfate | 0615-8325 |
| >Company | >Ingredient | >NDC |
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
hydroxychloroquine drug variants containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Aphena Pharma Solutions - Tennessee LLC | hydroxychloroquine sulfate | 43353-051 |
| Advanz Pharma (US) Corp | hydroxychloroquine sulfate | 59212-562 |
| Prasco Laboratories | hydroxychloroquine sulfate | 66993-057 |
| RedPharm Drug Inc | hydroxychloroquine sulfate | 67296-1781 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine drug variants not containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
hydroxychloroquine drug variants containing CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
hydroxychloroquine drug variants not containing CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| NCS HealthCare of KY Inc dba Vangard Labs | hydroxychloroquine sulfate | 0615-8325 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARNAUBA WAX
hydroxychloroquine drug variants containing CARNAUBA WAX
hydroxychloroquine drug variants not containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
hydroxychloroquine drug variants containing CELLULOSE, MICROCRYSTALLINE
hydroxychloroquine drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CI 77891
hydroxychloroquine drug variants containing CI 77891
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | hydroxychloroquine sulfate | 50090-5573 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine drug variants not containing CI 77891
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
hydroxychloroquine drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Mylan Institutional Inc | hydroxychloroquine sulfate | 42292-011 |
| A-S Medication Solutions | hydroxychloroquine sulfate | 50090-4659 |
| A-S Medication Solutions | hydroxychloroquine sulfate | 50090-5388 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| NCS HealthCare of KY Inc dba Vangard Labs | hydroxychloroquine sulfate | 0615-8325 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
hydroxychloroquine drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| Major Pharmaceuticals | hydroxychloroquine sulfate | 0904-7046 |
| Rising Pharma Holdings Inc | hydroxychloroquine sulfate | 16571-687 |
| Laurus Labs Limited | hydroxychloroquine sulfate | 42385-927 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine drug variants not containing CROSPOVIDONE
Excipient focus: DEXTRATES
hydroxychloroquine drug variants containing DEXTRATES
hydroxychloroquine drug variants not containing DEXTRATES
Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE
hydroxychloroquine drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
hydroxychloroquine drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
hydroxychloroquine drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | hydroxychloroquine sulfate | 63629-4465 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
hydroxychloroquine drug variants containing FERROSOFERRIC OXIDE
hydroxychloroquine drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
hydroxychloroquine drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | hydroxychloroquine sulfate | 0781-1407 |
| Sandoz Inc | hydroxychloroquine sulfate | 0781-5994 |
| Major Pharmaceuticals | hydroxychloroquine sulfate | 0904-6884 |
| Northstar RxLLC | hydroxychloroquine sulfate | 16714-753 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
hydroxychloroquine drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| NCS HealthCare of KY Inc dba Vangard Labs | hydroxychloroquine sulfate | 0615-8325 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
hydroxychloroquine drug variants containing HYPROMELLOSE 2910
hydroxychloroquine drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| NCS HealthCare of KY Inc dba Vangard Labs | hydroxychloroquine sulfate | 0615-8325 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
hydroxychloroquine drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | hydroxychloroquinesulfate | 68180-120 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
hydroxychloroquine drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| NCS HealthCare of KY LLC dba Vangard Labs | hydroxychloroquine sulfate | 0615-8401 |
| Major Pharmaceuticals | hydroxychloroquine sulfate | 0904-7046 |
| Rising Pharma Holdings Inc | hydroxychloroquine sulfate | 16571-112 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM ALUMINUM SILICATE
hydroxychloroquine drug variants containing MAGNESIUM ALUMINUM SILICATE
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | hydroxychloroquinesulfate | 68180-120 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine drug variants not containing MAGNESIUM ALUMINUM SILICATE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
hydroxychloroquine drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MALTODEXTRIN
hydroxychloroquine drug variants containing MALTODEXTRIN
hydroxychloroquine drug variants not containing MALTODEXTRIN
Excipient focus: POLYDEXTROSE
hydroxychloroquine drug variants containing POLYDEXTROSE
hydroxychloroquine drug variants not containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| NCS HealthCare of KY LLC dba Vangard Labs | hydroxychloroquine sulfate | 0615-8401 |
| NCS HealthCare of KY LLC dba Vangard Labs | hydroxychloroquine sulfate | 0615-8459 |
| Sandoz Inc | hydroxychloroquine sulfate | 0781-1407 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
hydroxychloroquine drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| NCS HealthCare of KY Inc dba Vangard Labs | hydroxychloroquine sulfate | 0615-8325 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 3350
hydroxychloroquine drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | hydroxychloroquine sulfate | 50090-4659 |
| DOH CENTRAL PHARMACY | hydroxychloroquine sulfate | 53808-1112 |
| Amneal Pharmaceuticals NY LLC | hydroxychloroquine sulfate | 60219-1544 |
| Coupler LLC | hydroxychloroquine sulfate | 67046-1523 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine drug variants not containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
hydroxychloroquine drug variants containing POLYETHYLENE GLYCOL 400
hydroxychloroquine drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 4000
hydroxychloroquine drug variants containing POLYETHYLENE GLYCOL 4000
hydroxychloroquine drug variants not containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 8000
hydroxychloroquine drug variants containing POLYETHYLENE GLYCOL 8000
hydroxychloroquine drug variants not containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| NCS HealthCare of KY Inc dba Vangard Labs | hydroxychloroquine sulfate | 0615-8325 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOLS
hydroxychloroquine drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | hydroxychloroquinesulfate | 68180-120 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine drug variants not containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
hydroxychloroquine drug variants containing POLYSORBATE 80
hydroxychloroquine drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
hydroxychloroquine drug variants containing POLYVINYL ALCOHOL
hydroxychloroquine drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
hydroxychloroquine drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Sandoz Inc | hydroxychloroquine sulfate | 0781-1407 |
| Sandoz Inc | hydroxychloroquine sulfate | 0781-5994 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine drug variants not containing POVIDONE
Excipient focus: POVIDONE K30
hydroxychloroquine drug variants containing POVIDONE K30
hydroxychloroquine drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
hydroxychloroquine drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Jubilant Cadista Pharmaceuticals Inc | hydroxychloroquine sulfate | 59746-780 |
| Havix Group Inc d-b-a Aavis Pharmaceuticals | hydroxychloroquine sulfate | 71337-019 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
hydroxychloroquine drug variants containing SHELLAC
hydroxychloroquine drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
hydroxychloroquine drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| NCS HealthCare of KY Inc dba Vangard Labs | hydroxychloroquine sulfate | 0615-8325 |
| A-S Medication Solutions | hydroxychloroquine sulfate | 50090-2508 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine drug variants not containing SILICON DIOXIDE
Excipient focus: SILODRATE
hydroxychloroquine drug variants containing SILODRATE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine drug variants not containing SILODRATE
Excipient focus: SODIUM BICARBONATE
hydroxychloroquine drug variants containing SODIUM BICARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | hydroxychloroquine sulfate | 0781-1407 |
| Sandoz Inc | hydroxychloroquine sulfate | 0781-5994 |
| Major Pharmaceuticals | hydroxychloroquine sulfate | 0904-6884 |
| Northstar RxLLC | hydroxychloroquine sulfate | 16714-753 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine drug variants not containing SODIUM BICARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
hydroxychloroquine drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Mylan Institutional Inc | hydroxychloroquine sulfate | 42292-011 |
| A-S Medication Solutions | hydroxychloroquine sulfate | 50090-4659 |
| A-S Medication Solutions | hydroxychloroquine sulfate | 50090-5388 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| NCS HealthCare of KY Inc dba Vangard Labs | hydroxychloroquine sulfate | 0615-8325 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
hydroxychloroquine drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
hydroxychloroquine drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: STARCH, CORN
hydroxychloroquine drug variants containing STARCH, CORN
hydroxychloroquine drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Sandoz Inc | hydroxychloroquine sulfate | 0781-1407 |
| Sandoz Inc | hydroxychloroquine sulfate | 0781-5994 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, PREGELATINIZED CORN
hydroxychloroquine drug variants containing STARCH, PREGELATINIZED CORN
| Company | Ingredient | NDC |
|---|---|---|
| NuCare PharmaceuticalsInc | hydroxychloroquine sulfate | 68071-4648 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine drug variants not containing STARCH, PREGELATINIZED CORN
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: SUCRALOSE
hydroxychloroquine drug variants containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Novitium Pharma LLC | hydroxychloroquine sulfate | 70954-172 |
| ANI Pharmaceuticals Inc | hydroxychloroquine sulfate | 70954-804 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine drug variants not containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
hydroxychloroquine drug variants containing TALC
hydroxychloroquine drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
hydroxychloroquine drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | hydroxychloroquine sulfate | 50090-5573 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
hydroxychloroquine drug variants containing TRIACETIN
hydroxychloroquine drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| NCS HealthCare of KY LLC dba Vangard Labs | hydroxychloroquine sulfate | 0615-8401 |
| NCS HealthCare of KY LLC dba Vangard Labs | hydroxychloroquine sulfate | 0615-8459 |
| Sandoz Inc | hydroxychloroquine sulfate | 0781-1407 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
hydroxychloroquine drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Novitium Pharma LLC | hydroxychloroquine sulfate | 70954-172 |
| ANI Pharmaceuticals Inc | hydroxychloroquine sulfate | 70954-804 |
| >Company | >Ingredient | >NDC |
hydroxychloroquine drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | hydroxychloroquine | 62135-752 |
| Teva Pharmaceuticals USA Inc | hydroxychloroquine sulfate | 0093-2401 |
| Mylan Pharmaceuticals Inc | hydroxychloroquine sulfate | 0378-0373 |
| Actavis Pharma Inc | hydroxychloroquine sulfate | 0591-3041 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
